Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5c81a01c66bc0e51e95841c0e64aee4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 |
filingDate |
2005-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c7b8463f713bb58f3051e3671984c4 |
publicationDate |
2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006040867-A1 |
titleOfInvention |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
abstract |
A novel method of treating and preventing viral infection is provided. In particular a method of blocking viral infection facilitated by a serine proteolytic (SP) activity is disclosed, which consists of administering to a subject suffering or about to suffer from viral infection a therapeutically effective amount of a compound having a serine protease inhibitory or serpin activity. Among compounds are α 1 -antitrypsin (AAT), peptide derivatives from the carboxyterminal end of AAT, and man-made, synthetic compounds mimicking the action of such compounds. The preferred viral infections include retroviral infection such as human immunodeficiency virus (HIV) infection. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011041325-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11046752-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011050098-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011041325-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10400029-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730929-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10723785-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229537-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012035034-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2698655-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2727452-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2728861-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403896-B2 |
priorityDate |
1999-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |